WHO naming stem · suffix · 26 listed names
-tecan
This page was written with AI.
antineoplastics, topoisomerase I inhibitors
Where it sits in a name
WHO writes the stem as -tecan. So the letters tecan sit at the end of the name (…tecan).
All 26 names WHO lists under -tecan
These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.
Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 4 of 26 names appear in these lists: 4 in the US list (FDA Drugs@FDA) and 4 in the EU central list (EMA); 4 have national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.
- afeletecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- atiratecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- belotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- cositecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- davamotecan pegadexamerNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- delimotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- diflomotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- elemotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- etirinotecan pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- exatecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- exatecan alideximerNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- firtecan peglumerNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- firtecan pegolNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- gimatecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- irinotecanEU (central) brands: Onivyde pegylated liposomal
- labetuzumab govitecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- locnartecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- lurtotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- mureletecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- namitecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- pegamotecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- rubitecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- sacituzumab govitecanUS brands: TRODELVYEU (central) brands: Trodelvy
- tenifatecanNot found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
- topotecanUS brands: HYCAMTINEU (central) brands: Hycamtin, Potactasol, Topotecan Hospira, Evotopin (withdrawn), Topotecan Actavis (withdrawn), Topotecan Eagle (withdrawn), Topotecan Teva (withdrawn)
- trastuzumab deruxtecanUS brands: ENHERTUFDA writes it FAM-TRASTUZUMAB DERUXTECANEU (central) brands: Enhertu
US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.
EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.
EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.
Decode another name
Decoded
exatecan
Listed INNCarries the WHO stem -tecan
- -tecanend of the nameWHO lists it hereWHO definition: antineoplastics, topoisomerase I inhibitors
“exatecan” is an INN that WHO lists under -tecan in the 2024 stem book.
The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.
Source and licence
The definition of -tecan (Part II B) and the 26 names (Part IV, group (a)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .
Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.